Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.
Press releases published on October 26, 2025
MapLight Therapeutics Announces Pricing of Initial Public Offering
SAN FRANCISCO and BOSTON, Oct. 26, 2025 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced the …
New Global Coalition Launches to Address the Hidden Threat of RSV in Adults
VIENNA, Austria, Oct. 26, 2025 (GLOBE NEWSWIRE) -- A new global coalition, the RSV Alliance, has been launched to raise awareness about the risks of respiratory syncytial virus (RSV) infections, with a focus on aging populations and individuals with …
New Data at American College of Gastroenterology Annual Meeting Show TissueCypher® Provides Actionable Risk Insights that Influence Clinical Management and Prompt Risk-Aligned Intervention in Barrett’s Esophagus
FRIENDSWOOD, Texas, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating that its TissueCypher® Barrett’s Esophagus …
Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Systemic Lupus Erythematosus Treated with FT819 Off-the-Shelf CAR T-Cell Therapy
As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were treated with a single dose of FT819 with less-intensive or no conditioning chemotherapy Favorable safety profile …
mediCAD® 8 Revolutionizes Orthopedic and Trauma Planning with Intelligent AI Integration
LANDSHUT, Germany, Oct. 26, 2025 (GLOBE NEWSWIRE) -- The latest release of mediCAD® 8 by mediCAD Hectec GmbH marks a new era in intelligent orthopedic and trauma planning. Combining artificial intelligence, automation, and with a completely new user …
Polpharma Group gibt Führungswechsel bekannt – Ernennung von Sebastian Szymanek zum neuen Präsidenten
AMSTERDAM, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Die Polpharma Group, eines der größten Pharmaunternehmen in Mittel- und Osteuropa sowie Zentralasien, gibt einen geplanten Führungswechsel bekannt. Mit Wirkung zum 1. Januar 2026 wird Markus Sieger nach zehn …
Polpharma Group annonce un changement de direction – Sebastian Szymanek nommé nouveau président
AMSTERDAM, 26 oct. 2025 (GLOBE NEWSWIRE) -- Polpharma Group, l’un des plus grands groupes pharmaceutiques opérant en Europe centrale, orientale et en Asie centrale, annonce une transition planifiée de sa direction. À compter du 1er janvier 2026, Markus …